Literature DB >> 11185739

Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure.

S Ogawa1, M Emi, M Shiraki, T Hosoi, Y Ouchi, S Inoue.   

Abstract

We investigated the association between a dinucleotide (cytosine-adenine; CA) repeat polymorphism located in the flanking region of the human estrogen receptor beta (ESR2) gene and systemic blood pressure in 187 healthy postmenopausal Japanese women. The genotype was classified as "A" through "O" according to the number of these repeats from 18 to 32. When we separated the subjects into two groups-- bearing at least one "I" allele (26 CA repeats) and those who did not--we found that the former subjects had significantly higher systolic blood pressure than the latter (mean +/- SD, 146.0 +/- 25.0 vs 136.6 +/- 23.4; P = 0.032). These data suggest that genetic variation at the ESR2 locus may be associated with some determinants of blood pressure, and that there is a possible involvement of this polymorphism in causing hypertension in Japanese women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11185739     DOI: 10.1007/s100380070002

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  15 in total

1.  Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase.

Authors:  Isabella Baruscotti; Federica Barchiesi; Edwin K Jackson; Bruno Imthurn; Ruth Stiller; Jai-Hyun Kim; Sara Schaufelberger; Marinella Rosselli; Christopher C W Hughes; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

2.  Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome.

Authors:  Hanna Gräns; Maria Nilsson; Karin Dahlman-Wright; Birgitta Evengård
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

Review 3.  Estrogen and hypertension.

Authors:  Muhammad S Ashraf; Wanpen Vongpatanasin
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

4.  The Association of Estrogen Receptor-β Gene Variation With Salt-Sensitive Blood Pressure.

Authors:  Worapaka Manosroi; Jia Wei Tan; Chevon M Rariy; Bei Sun; Mark O Goodarzi; Aditi R Saxena; Jonathan S Williams; Luminita H Pojoga; Jessica Lasky-Su; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der I Chen; Anny H Xiang; Willa A Hsueh; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams; Ellen W Seely
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

5.  Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.

Authors:  Barbara K Dunn; Mark H Greene; Jenny M Kelley; Joseph P Costantino; Robert J Clifford; Ying Hu; Gong Tang; Neely Kazerouni; Philip S Rosenberg; Daoud M Meerzaman; Kenneth H Buetow
Journal:  Int J Mol Epidemiol Genet       Date:  2010-09-05

6.  Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.

Authors:  O A Press; W Zhang; M A Gordon; D Yang; C A Haiman; M Azuma; S Iqbal; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2010-06-15       Impact factor: 3.550

Review 7.  Gender differences in abdominal aortic aneurysms.

Authors:  Kevin K Hannawa; Jonathan L Eliason; Gilbert R Upchurch
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

Review 8.  Estrogen receptors and human disease.

Authors:  Bonnie J Deroo; Kenneth S Korach
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

9.  Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women.

Authors:  Kathryn M Rexrode; Paul M Ridker; Hillary H Hegener; Julie E Buring; Joann E Manson; Robert Y L Zee
Journal:  Clin Chem       Date:  2007-08-16       Impact factor: 8.327

10.  Polymorphisms of estrogen receptor beta gene are associated with hypospadias.

Authors:  A Beleza-Meireles; D Omrani; I Kockum; L Frisén; K Lagerstedt; A Nordenskjöld
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.